Arcus Biosciences, Inc.RCUSNYSE
Loading
Year-over-year operating cash flow growth rate
Percentile
P40
Within normal range
vs 3Y Ago
-1.7x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -23.71% |
| Q3 2025 | 27.07% |
| Q2 2025 | -0.76% |
| Q1 2025 | -32.00% |
| Q4 2024 | -484.62% |
| Q3 2024 | 127.66% |
| Q2 2024 | -4600.00% |
| Q1 2024 | 97.73% |
| Q4 2023 | -39.68% |
| Q3 2023 | -10.53% |
| Q2 2023 | 41.84% |
| Q1 2023 | -40.52% |
| Q4 2022 | 13.86% |
| Q3 2022 | -24.55% |
| Q2 2022 | -109.94% |
| Q1 2022 | 1153.09% |
| Q4 2021 | -15.53% |
| Q3 2021 | 27.35% |
| Q2 2021 | -11.58% |
| Q1 2021 | -32.95% |
| Q4 2020 | -123.06% |
| Q3 2020 | 1003.44% |
| Q2 2020 | 23.46% |
| Q1 2020 | -230.24% |
| Q4 2019 | 65.43% |
| Q3 2019 | -38.71% |
| Q2 2019 | -17.31% |
| Q1 2019 | -136.94% |
| Q4 2018 | 39.59% |
| Q3 2018 | -8.16% |
| Q2 2018 | 17.89% |
| Q1 2018 | -184.99% |
| Q4 2017 | 164.32% |
| Q3 2017 | -255.60% |
| Q2 2017 | 28.99% |
| Q1 2017 | 0.00% |